Wall Street Analysts Believe Karyopharm Therapeutics (KPTI) Could Rally 56.06%: Here's is How to Trade

Karyopharm Therapeutics (KPTI) closed the last trading session at $9.4, gaining 58% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $14.67 indicates a 56.1% upside potential.The mean estimate comprises six short-term price targets with a standard deviation of $5.32. While the lowest estimate of $6.00 indicates a 36.2% decline from the current price level, the most optimistic analys ...